APO PHARM ApS: Financial statements 2022
CVR: 15226072
Source: annual report 2022, Danish Business Authority
01/07/2021 – 30/06/2022
APO PHARM ApS (CVR 15226072) has filed annual accounts for 2022. In 2022, the company reported a gross profit of DKK 1,277,410 and a net result of DKK 253,739 compared with DKK 565,778 the year before. That is a decrease of 23.6% compared with the year before. Equity in the 2022 report amounted to DKK 691,266. The solvency ratio was 31.9%. The company had 6 employees in the financial year.
- Gross Profit
- DKK 1,277,410
- Profit/Loss
- DKK 253,739
- Equity
- DKK 691,266
- Total Assets
- DKK 2,169,369
- Employees
- 6
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2022 | - | 1.3 mio. | 254 t. | 691 t. | 6 |
| 2021 | - | 1.7 mio. | 566 t. | 1 mio. | 6 |
| 2020 | - | 2.1 mio. | 678 t. | 1.1 mio. | 6 |
| 2019 | - | 1.8 mio. | 748 t. | 1.1 mio. | 5 |
| 2018 | - | 1.2 mio. | 66 t. | 345 t. | 5 |
Official annual report
Keep an eye on APO PHARM ApS
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringAbout APO PHARM ApS
APO PHARM ApS is a Danish company of the type Anpartsselskab based in Holbæk, founded in 1991. The company is registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The company was previously named VITALISTEN ApS. The management consists of Helge Larsen. The board consists of Hanne Vesti Petersen and Helge Larsen. The company is owned by VESTI LARSEN ApS. The company has 7 employees (2026). In 2025, the company reported a gross profit of DKK 1,481,073 and a net result of DKK 26,824 compared with DKK 121,257 the year before. Equity in the 2025 report amounted to DKK 332,307.